104 related articles for article (PubMed ID: 22710395)
1. Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion.
Geldenhuys WJ; Darvesh AS; Dluzen DE
Neurochem Int; 2012 Jun; 60(8):806-8. PubMed ID: 22710395
[TBL] [Abstract][Full Text] [Related]
2. The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
Miller DB; Ali SF; O'Callaghan JP; Laws SC
Ann N Y Acad Sci; 1998 May; 844():153-65. PubMed ID: 9668673
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice.
Willett MC; Dluzen DE
Brain Res; 2004 Dec; 1029(2):186-94. PubMed ID: 15542073
[TBL] [Abstract][Full Text] [Related]
5. Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice.
McGrew DM; Irwin I; Langston JW
Neurotoxicology; 2000 Jun; 21(3):309-12. PubMed ID: 10894120
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice.
Fornai F; Bassi L; Torracca MT; Scalori V; Corsini GU
Eur J Pharmacol; 1995 Sep; 283(1-3):99-102. PubMed ID: 7498327
[TBL] [Abstract][Full Text] [Related]
7. Indirubins deplete striatal monoamines in the Intact and MPTP-treated mouse brain and block kainate-induced striatal astrogliosis.
Magiatis P; Polychronopoulos P; Skaltsounis AL; Lozach O; Meijer L; Miller DB; O'Callaghan JP
Neurotoxicol Teratol; 2010; 32(2):212-9. PubMed ID: 20034560
[TBL] [Abstract][Full Text] [Related]
8. Estrogen, testosterone, and methamphetamine toxicity.
Dluzen DE; McDermott JL
Ann N Y Acad Sci; 2006 Aug; 1074():282-94. PubMed ID: 17105924
[TBL] [Abstract][Full Text] [Related]
9. Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice.
Lewis C; Dluzen DE
Neurosci Lett; 2008 Dec; 448(1):130-3. PubMed ID: 18852023
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
Bourque M; Liu B; Dluzen DE; Di Paolo T
Biochem Pharmacol; 2007 Nov; 74(9):1413-23. PubMed ID: 17825264
[TBL] [Abstract][Full Text] [Related]
11. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
Khan HA
Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
[TBL] [Abstract][Full Text] [Related]
12. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
[TBL] [Abstract][Full Text] [Related]
13. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
15. Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice.
Ookubo M; Yokoyama H; Takagi S; Kato H; Araki T
Mol Cell Endocrinol; 2008 Dec; 296(1-2):87-93. PubMed ID: 18755240
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
17. Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity.
Battaglia G; Gesi M; Lenzi P; Busceti CL; Soldani P; Orzi F; Rampello L; Nicoletti F; Ruggieri S; Fornai F
Ann N Y Acad Sci; 2002 Jun; 965():254-66. PubMed ID: 12105101
[TBL] [Abstract][Full Text] [Related]
18. Parity decreases methamphetamine-induced striatal dopaminergic perturbation.
Dluzen DE
Neurochem Int; 2011 Aug; 59(2):101-3. PubMed ID: 21693145
[TBL] [Abstract][Full Text] [Related]
19. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
Dluzen DE; McDermott JL; Darvesh AS
Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
[TBL] [Abstract][Full Text] [Related]
20. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
